APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Carbohydrate Antigen 19-9

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Carbohydrate Antigen 19-9 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173974940329 December 2025193 pages

Choose your research edition.

Industry ResearchCarbohydrate Antigen 19-9 Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbohydrate Antigen 19-9 Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Carbohydrate Antigen 19-9 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbohydrate Antigen 19-9 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbohydrate Antigen 19-9 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Carbohydrate Antigen 19-9 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Carbohydrate Antigen 19-9 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Carbohydrate Antigen 19-9 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carbohydrate Antigen 19-9 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Carbohydrate Antigen 19-9 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carbohydrate Antigen 19-9 include BioMérieux, Danaher Corporation, DiaSorin, Fujirebio, KAINOS Laboratories, Ortho Clinical Diagnostics, Siemens, DIACHA Diagnostics and Dirui, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Carbohydrate Antigen 19-9 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Carbohydrate Antigen 19-9 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Carbohydrate Antigen 19-9 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Carbohydrate Antigen 19-9 market size, projected growth trends, production technologies, key applications, and end-use industries.

Carbohydrate Antigen 19-9 Segment by Company

BioMérieux

Danaher Corporation

DiaSorin

Fujirebio

KAINOS Laboratories

Ortho Clinical Diagnostics

Siemens

DIACHA Diagnostics

Dirui

Roche

Chemclin IVD

Tellgen

Sichuan Maccura Biotechnology

Abbott

Carbohydrate Antigen 19-9 Segment by Type

ELISA

CLIA

Carbohydrate Antigen 19-9 Segment by Application

Pancreatic Cancer

Stomach Cancer

Colon Cancer

Others

Carbohydrate Antigen 19-9 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbohydrate Antigen 19-9 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbohydrate Antigen 19-9 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbohydrate Antigen 19-9.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Carbohydrate Antigen 19-9 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carbohydrate Antigen 19-9 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Carbohydrate Antigen 19-9 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Carbohydrate Antigen 19-9 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Carbohydrate Antigen 19-9 Industry Trends Table 2. Carbohydrate Antigen 19-9 Industry Drivers Table 3. Carbohydrate Antigen 19-9 Industry Opportunities and Challenges Table 4. Carbohydrate Antigen 19-9 Industry Restraints Table 5. Global Carbohydrate Antigen 19-9 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Carbohydrate Antigen 19-9 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Carbohydrate Antigen 19-9 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Carbohydrate Antigen 19-9 Sales Market Share by Manufacturers Table 9. Global Carbohydrate Antigen 19-9 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Carbohydrate Antigen 19-9 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Carbohydrate Antigen 19-9 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Carbohydrate Antigen 19-9 Manufacturers, Product Type & Application Table 13. Global Carbohydrate Antigen 19-9 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Carbohydrate Antigen 19-9 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ELISA Table 17. Major Manufacturers of CLIA Table 18. Global Carbohydrate Antigen 19-9 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Carbohydrate Antigen 19-9 Sales by Type (2021-2026) & (K Units) Table 20. Global Carbohydrate Antigen 19-9 Sales by Type (2027-2032) & (K Units) Table 21. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021-2026) Table 22. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2027-2032) Table 23. Global Carbohydrate Antigen 19-9 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Carbohydrate Antigen 19-9 Revenue by Type (2021-2026) & (K Units) Table 25. Global Carbohydrate Antigen 19-9 Revenue by Type (2027-2032) & (K Units) Table 26. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021-2026) Table 27. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pancreatic Cancer Table 29. Major Manufacturers of Stomach Cancer Table 30. Major Manufacturers of Colon Cancer Table 31. Major Manufacturers of Others Table 32. Global Carbohydrate Antigen 19-9 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Carbohydrate Antigen 19-9 Sales by Application (2021-2026) & (K Units) Table 34. Global Carbohydrate Antigen 19-9 Sales by Application (2027-2032) & (K Units) Table 35. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021-2026) Table 36. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2027-2032) Table 37. Global Carbohydrate Antigen 19-9 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Carbohydrate Antigen 19-9 Revenue by Application (2021-2026) & (K Units) Table 39. Global Carbohydrate Antigen 19-9 Revenue by Application (2027-2032) & (K Units) Table 40. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021-2026) Table 41. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2027-2032) Table 42. Global Carbohydrate Antigen 19-9 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Carbohydrate Antigen 19-9 Sales by Region (2021-2026) & (K Units) Table 44. Global Carbohydrate Antigen 19-9 Sales Market Share by Region (2021-2026) Table 45. Global Carbohydrate Antigen 19-9 Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Carbohydrate Antigen 19-9 Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 49. North America Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 50. Europe Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 52. Europe Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2027-2032) & (K Units) Table 59. Global Carbohydrate Antigen 19-9 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Carbohydrate Antigen 19-9 Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Carbohydrate Antigen 19-9 Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2021-2026) Table 63. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2027-2032) Table 64. BioMérieux Company Information Table 65. BioMérieux Business Overview Table 66. BioMérieux Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. BioMérieux Carbohydrate Antigen 19-9 Product Portfolio Table 68. BioMérieux Recent Development Table 69. Danaher Corporation Company Information Table 70. Danaher Corporation Business Overview Table 71. Danaher Corporation Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Danaher Corporation Carbohydrate Antigen 19-9 Product Portfolio Table 73. Danaher Corporation Recent Development Table 74. DiaSorin Company Information Table 75. DiaSorin Business Overview Table 76. DiaSorin Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. DiaSorin Carbohydrate Antigen 19-9 Product Portfolio Table 78. DiaSorin Recent Development Table 79. Fujirebio Company Information Table 80. Fujirebio Business Overview Table 81. Fujirebio Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Fujirebio Carbohydrate Antigen 19-9 Product Portfolio Table 83. Fujirebio Recent Development Table 84. KAINOS Laboratories Company Information Table 85. KAINOS Laboratories Business Overview Table 86. KAINOS Laboratories Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. KAINOS Laboratories Carbohydrate Antigen 19-9 Product Portfolio Table 88. KAINOS Laboratories Recent Development Table 89. Ortho Clinical Diagnostics Company Information Table 90. Ortho Clinical Diagnostics Business Overview Table 91. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Portfolio Table 93. Ortho Clinical Diagnostics Recent Development Table 94. Siemens Company Information Table 95. Siemens Business Overview Table 96. Siemens Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Siemens Carbohydrate Antigen 19-9 Product Portfolio Table 98. Siemens Recent Development Table 99. DIACHA Diagnostics Company Information Table 100. DIACHA Diagnostics Business Overview Table 101. DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Portfolio Table 103. DIACHA Diagnostics Recent Development Table 104. Dirui Company Information Table 105. Dirui Business Overview Table 106. Dirui Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Dirui Carbohydrate Antigen 19-9 Product Portfolio Table 108. Dirui Recent Development Table 109. Roche Company Information Table 110. Roche Business Overview Table 111. Roche Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Roche Carbohydrate Antigen 19-9 Product Portfolio Table 113. Roche Recent Development Table 114. Chemclin IVD Company Information Table 115. Chemclin IVD Business Overview Table 116. Chemclin IVD Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Chemclin IVD Carbohydrate Antigen 19-9 Product Portfolio Table 118. Chemclin IVD Recent Development Table 119. Tellgen Company Information Table 120. Tellgen Business Overview Table 121. Tellgen Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Tellgen Carbohydrate Antigen 19-9 Product Portfolio Table 123. Tellgen Recent Development Table 124. Sichuan Maccura Biotechnology Company Information Table 125. Sichuan Maccura Biotechnology Business Overview Table 126. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Portfolio Table 128. Sichuan Maccura Biotechnology Recent Development Table 129. Abbott Company Information Table 130. Abbott Business Overview Table 131. Abbott Carbohydrate Antigen 19-9 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Abbott Carbohydrate Antigen 19-9 Product Portfolio Table 133. Abbott Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Carbohydrate Antigen 19-9 Distributors List Table 137. Carbohydrate Antigen 19-9 Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Carbohydrate Antigen 19-9 Product Image Figure 2. Global Carbohydrate Antigen 19-9 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbohydrate Antigen 19-9 Market Size (2021-2032) & (US$ Million) Figure 4. Global Carbohydrate Antigen 19-9 Sales (2021-2032) & (K Units) Figure 5. Global Carbohydrate Antigen 19-9 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Carbohydrate Antigen 19-9 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ELISA Image Figure 9. CLIA Image Figure 10. Global Carbohydrate Antigen 19-9 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Carbohydrate Antigen 19-9 Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021-2032) Figure 13. Global Carbohydrate Antigen 19-9 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Carbohydrate Antigen 19-9 Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021-2032) Figure 16. Pancreatic Cancer Image Figure 17. Stomach Cancer Image Figure 18. Colon Cancer Image Figure 19. Others Image Figure 20. Global Carbohydrate Antigen 19-9 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Carbohydrate Antigen 19-9 Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021-2032) Figure 23. Global Carbohydrate Antigen 19-9 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Carbohydrate Antigen 19-9 Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021-2032) Figure 26. North America Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 28. U.S. Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 33. Germany Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 40. China Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Carbohydrate Antigen 19-9 Sales Market Share by Country (2021-2032) Figure 48. Brazil Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Carbohydrate Antigen 19-9 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Carbohydrate Antigen 19-9 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Carbohydrate Antigen 19-9 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Carbohydrate Antigen 19-9 Revenue (2021-2032) & (US$ Million) Figure 59. North America Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Carbohydrate Antigen 19-9 Revenue (2021-2032) & (US$ Million) Figure 61. Europe Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Carbohydrate Antigen 19-9 Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Carbohydrate Antigen 19-9 Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Carbohydrate Antigen 19-9 Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Carbohydrate Antigen 19-9 Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • CLIA
Applications
  • Pancreatic Cancer
  • Stomach Cancer
  • Colon Cancer
  • Others
Companies covered
  • BioMérieux
  • Danaher Corporation
  • DiaSorin
  • Fujirebio
  • KAINOS Laboratories
  • Ortho Clinical Diagnostics
  • Siemens
  • DIACHA Diagnostics
  • Dirui
  • Roche
  • Chemclin IVD
  • Tellgen
  • Sichuan Maccura Biotechnology
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Carbohydrate Antigen 19-9 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Carbohydrate Antigen 19-9 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Carbohydrate Antigen 19-9 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Carbohydrate Antigen 19-9 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Carbohydrate Antigen 19-9 Market Dynamics
  1. 2.1 Carbohydrate Antigen 19-9 Industry Trends
  2. 2.2 Carbohydrate Antigen 19-9 Industry Drivers
  3. 2.3 Carbohydrate Antigen 19-9 Industry Opportunities and Challenges
  4. 2.4 Carbohydrate Antigen 19-9 Industry Restraints
3 Carbohydrate Antigen 19-9 Market by Manufacturers
  1. 3.1 Global Carbohydrate Antigen 19-9 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Carbohydrate Antigen 19-9 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Carbohydrate Antigen 19-9 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Carbohydrate Antigen 19-9 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carbohydrate Antigen 19-9 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Carbohydrate Antigen 19-9 Manufacturers, Product Type & Application
  7. 3.7 Global Carbohydrate Antigen 19-9 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carbohydrate Antigen 19-9 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carbohydrate Antigen 19-9 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carbohydrate Antigen 19-9 Tier 1, Tier 2, and Tier 3
4 Carbohydrate Antigen 19-9 Market by Type
  1. 4.1 Carbohydrate Antigen 19-9 Type Introduction
  2. 4.1.1 ELISA
  3. 4.1.2 CLIA
  4. 4.2 Global Carbohydrate Antigen 19-9 Sales by Type
  5. 4.2.1 Global Carbohydrate Antigen 19-9 Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Carbohydrate Antigen 19-9 Sales by Type (2021-2032)
  7. 4.2.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2021-2032)
  8. 4.3 Global Carbohydrate Antigen 19-9 Revenue by Type
  9. 4.3.1 Global Carbohydrate Antigen 19-9 Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Carbohydrate Antigen 19-9 Revenue by Type (2021-2032)
  11. 4.3.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2021-2032)
5 Carbohydrate Antigen 19-9 Market by Application
  1. 5.1 Carbohydrate Antigen 19-9 Application Introduction
  2. 5.1.1 Pancreatic Cancer
  3. 5.1.2 Stomach Cancer
  4. 5.1.3 Colon Cancer
  5. 5.1.4 Others
  6. 5.2 Global Carbohydrate Antigen 19-9 Sales by Application
  7. 5.2.1 Global Carbohydrate Antigen 19-9 Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Carbohydrate Antigen 19-9 Sales by Application (2021-2032)
  9. 5.2.3 Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2021-2032)
  10. 5.3 Global Carbohydrate Antigen 19-9 Revenue by Application
  11. 5.3.1 Global Carbohydrate Antigen 19-9 Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Carbohydrate Antigen 19-9 Revenue by Application (2021-2032)
  13. 5.3.3 Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2021-2032)
6 Global Carbohydrate Antigen 19-9 Sales by Region
  1. 6.1 Global Carbohydrate Antigen 19-9 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Carbohydrate Antigen 19-9 Sales by Region (2021-2032)
  3. 6.2.1 Global Carbohydrate Antigen 19-9 Sales by Region (2021-2026)
  4. 6.2.2 Global Carbohydrate Antigen 19-9 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Carbohydrate Antigen 19-9 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Carbohydrate Antigen 19-9 Revenue by Region
  1. 7.1 Global Carbohydrate Antigen 19-9 Revenue by Region
  2. 7.1.1 Global Carbohydrate Antigen 19-9 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Carbohydrate Antigen 19-9 Revenue by Region (2021-2026)
  4. 7.1.3 Global Carbohydrate Antigen 19-9 Revenue by Region (2027-2032)
  5. 7.1.4 Global Carbohydrate Antigen 19-9 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Carbohydrate Antigen 19-9 Revenue (2021-2032)
  8. 7.2.2 North America Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Carbohydrate Antigen 19-9 Revenue (2021-2032)
  11. 7.3.2 Europe Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Carbohydrate Antigen 19-9 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Carbohydrate Antigen 19-9 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Carbohydrate Antigen 19-9 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BioMérieux
  2. 8.1.1 BioMérieux Company Information
  3. 8.1.2 BioMérieux Business Overview
  4. 8.1.3 BioMérieux Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BioMérieux Carbohydrate Antigen 19-9 Product Portfolio
  6. 8.1.5 BioMérieux Recent Developments
  7. 8.2 Danaher Corporation
  8. 8.2.1 Danaher Corporation Company Information
  9. 8.2.2 Danaher Corporation Business Overview
  10. 8.2.3 Danaher Corporation Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Danaher Corporation Carbohydrate Antigen 19-9 Product Portfolio
  12. 8.2.5 Danaher Corporation Recent Developments
  13. 8.3 DiaSorin
  14. 8.3.1 DiaSorin Company Information
  15. 8.3.2 DiaSorin Business Overview
  16. 8.3.3 DiaSorin Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DiaSorin Carbohydrate Antigen 19-9 Product Portfolio
  18. 8.3.5 DiaSorin Recent Developments
  19. 8.4 Fujirebio
  20. 8.4.1 Fujirebio Company Information
  21. 8.4.2 Fujirebio Business Overview
  22. 8.4.3 Fujirebio Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fujirebio Carbohydrate Antigen 19-9 Product Portfolio
  24. 8.4.5 Fujirebio Recent Developments
  25. 8.5 KAINOS Laboratories
  26. 8.5.1 KAINOS Laboratories Company Information
  27. 8.5.2 KAINOS Laboratories Business Overview
  28. 8.5.3 KAINOS Laboratories Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 KAINOS Laboratories Carbohydrate Antigen 19-9 Product Portfolio
  30. 8.5.5 KAINOS Laboratories Recent Developments
  31. 8.6 Ortho Clinical Diagnostics
  32. 8.6.1 Ortho Clinical Diagnostics Company Information
  33. 8.6.2 Ortho Clinical Diagnostics Business Overview
  34. 8.6.3 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
  36. 8.6.5 Ortho Clinical Diagnostics Recent Developments
  37. 8.7 Siemens
  38. 8.7.1 Siemens Company Information
  39. 8.7.2 Siemens Business Overview
  40. 8.7.3 Siemens Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Siemens Carbohydrate Antigen 19-9 Product Portfolio
  42. 8.7.5 Siemens Recent Developments
  43. 8.8 DIACHA Diagnostics
  44. 8.8.1 DIACHA Diagnostics Company Information
  45. 8.8.2 DIACHA Diagnostics Business Overview
  46. 8.8.3 DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Portfolio
  48. 8.8.5 DIACHA Diagnostics Recent Developments
  49. 8.9 Dirui
  50. 8.9.1 Dirui Company Information
  51. 8.9.2 Dirui Business Overview
  52. 8.9.3 Dirui Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dirui Carbohydrate Antigen 19-9 Product Portfolio
  54. 8.9.5 Dirui Recent Developments
  55. 8.10 Roche
  56. 8.10.1 Roche Company Information
  57. 8.10.2 Roche Business Overview
  58. 8.10.3 Roche Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Roche Carbohydrate Antigen 19-9 Product Portfolio
  60. 8.10.5 Roche Recent Developments
  61. 8.11 Chemclin IVD
  62. 8.11.1 Chemclin IVD Company Information
  63. 8.11.2 Chemclin IVD Business Overview
  64. 8.11.3 Chemclin IVD Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chemclin IVD Carbohydrate Antigen 19-9 Product Portfolio
  66. 8.11.5 Chemclin IVD Recent Developments
  67. 8.12 Tellgen
  68. 8.12.1 Tellgen Company Information
  69. 8.12.2 Tellgen Business Overview
  70. 8.12.3 Tellgen Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tellgen Carbohydrate Antigen 19-9 Product Portfolio
  72. 8.12.5 Tellgen Recent Developments
  73. 8.13 Sichuan Maccura Biotechnology
  74. 8.13.1 Sichuan Maccura Biotechnology Company Information
  75. 8.13.2 Sichuan Maccura Biotechnology Business Overview
  76. 8.13.3 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Portfolio
  78. 8.13.5 Sichuan Maccura Biotechnology Recent Developments
  79. 8.14 Abbott
  80. 8.14.1 Abbott Company Information
  81. 8.14.2 Abbott Business Overview
  82. 8.14.3 Abbott Carbohydrate Antigen 19-9 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Abbott Carbohydrate Antigen 19-9 Product Portfolio
  84. 8.14.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Carbohydrate Antigen 19-9 Value Chain Analysis
  2. 9.1.1 Carbohydrate Antigen 19-9 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Carbohydrate Antigen 19-9 Production Mode & Process
  6. 9.2 Carbohydrate Antigen 19-9 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Carbohydrate Antigen 19-9 Distributors
  9. 9.2.3 Carbohydrate Antigen 19-9 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst